Medtronic principal accounting officer Kirk resigns; Blomquist named successor

Medtronic plc

Jennifer M. Kirk resigns as Global Controller & Principal Accounting Officer effective May 2, 2025 to become CEO of Exubrion Therapeutics.
Denise L. Blomquist, Assistant Global Controller, appointed as Global Controller & Principal Accounting Officer effective March 17, 2025.
Blomquist has 21-year Medtronic tenure; compensation aligns with similar officer positions under MIP, LTIP, and Change in Control Policy.
Kirk's departure not related to any disagreement over operations, policies, or practices; she will stay through May 2 for transition.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jennifer M. Kirk

Global Controller and Principal Accounting Officer

MDT · Medtronic plc

Effective: 2025-05-02
Successor: Denise L. Blomquist
Filed: March 17, 2025, 7:59 PM ET

On March 12, 2025, Jennifer M. Kirk, the Global Controller and Principal Accounting Officer of Medtronic plc (Company), notified the Company of her decision to resign from the Company, effective May 2, 2025, to become the chief executive officer of Exubrion Therapeutics, a privately held company.

Appointed

Denise L. Blomquist

Global Controller and Principal Accounting Officer

MDT · Medtronic plc

Effective: 2025-03-17
Filed: March 17, 2025, 7:59 PM ET

The Company has appointed Denise L. Blomquist, currently the Company's Assistant Global Controller, to succeed Ms. Kirk as the Company's Global Controller and Principal Accounting Officer, effective March 17, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jennifer M. Kirk resigned as Global Controller and Principal Accounting Officer at Medtronic plc.

Action: resigned
Role: Global Controller and Principal Accounting Officer

Exact text from the filing

On March 12, 2025, Jennifer M. Kirk, the Global Controller and Principal Accounting Officer of Medtronic plc (Company), notified the Company of her decision to resign from the Company, effective May 2, 2025, to become the chief executive officer of Exubrion Therapeutics, a privately held company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Denise L. Blomquist was appointed as Global Controller and Principal Accounting Officer at Medtronic plc.

Action: appointed
Role: Global Controller and Principal Accounting Officer

Exact text from the filing

The Company has appointed Denise L. Blomquist, currently the Company's Assistant Global Controller, to succeed Ms. Kirk as the Company's Global Controller and Principal Accounting Officer, effective March 17, 2025.

View on SEC.gov

Medtronic plc filing history →

Source: SEC EDGAR

accession 0001613103-25-000034

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.